The challenge of targets and drug discovery using large-scale screening approaches in onco-hematology

Area of Science:

• Onco-hematology
• Drug Discovery
• Cancer Research

Background:

• Target identification and drug discovery have significantly advanced in onco-hematology over recent decades.
• The development of novel therapeutics remains a critical need for improving patient outcomes.

Purpose of the Study:

• To review recent improvements in drug discovery for onco-hematology.
• To highlight the utility of physio-pathologically relevant models and innovative screening approaches.
• To discuss challenges and propose solutions using acute myeloid leukemia as a model.

Main Methods:

• Literature review of recent advancements in onco-hematology drug discovery.
• Analysis of innovative screening approaches and relevant disease models.
• Case study focusing on acute myeloid leukemia drug development.

Main Results:

• Physio-pathologically relevant models and innovative screening accelerate drug development.
• Acute myeloid leukemia serves as a key example for illustrating drug discovery pathways.
• Identified common pitfalls in the drug discovery journey.

Conclusions:

• Continuous improvement in models and screening is vital for efficient drug development in onco-hematology.
• Addressing identified pitfalls can optimize the drug discovery process.
• Enhanced strategies are needed to improve the journey of onco-hematology drug discovery.